Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

June
30
2026

How 2026 Code Changes Shifted SRT from Sensus Healthcare to a Standard Treatment Option

For nearly a century, surgical excision and Mohs surgery have been the gold standard for treating patients who have non-melanoma skin cancer (NMSC) and keloid disease. The surgery works extremely well – with cure rates…

September
29
2016

SRT-100™: A Painless, Non-Invasive, Non-Melanoma Skin Cancer Treatment Right in Your Office

Whether you are a radiation oncologist or a dermatologist, you can enhance your patient care with the SRT-100™ non-melanoma skin cancer treatment….
September
18
2016

SRT-100™: A Non-Melanoma Skin Cancer Treatment Your Body Can Handle, but Cancer Cannot

Skin cancer is the fastest growing cancer in the world. Experts predict the number of people diagnosed with non-melanoma skin cancer will grow to nearly six million by the year 2020. With the epidemic of…

August
16
2016

Treat Your Patients’ Basal Cell Carcinoma with the Revolutionary SRT-100™

Any dermatologist knows just how devastating a skin cancer diagnosis can be to his or her patients. Skin cancer is diagnosed nearly three times as often as any other form of cancer, with the most…

July
14
2016

The SRT-100™ Beats The Keloid Scar

A quick question for you–what do you tell your patients when they come into your office and inform you that they have a keloid scar they want to get rid of? Do you offer a…

Archives
Archives

IN THE NEWS

From Scalpel to SRT: Impact of Innovation on the Dermatology Industry